Advances in Electroacupuncture for Treatment of Knee Osteoarthritis: Mechanisms, Efficacy, and Future Directions.

Knee osteoarthritis is a common condition where the protective cartilage in your knee gradually wears away, causing pain, stiffness, and difficulty moving. This comprehensive review examined electroacupuncture (EA)—a treatment that combines traditional acupuncture needles with mild electrical stimulation—as a drug-free option for managing knee osteoarthritis.

Researchers analyzed how electroacupuncture works in the body and its effectiveness for knee pain and function. They found that EA appears to work through multiple mechanisms simultaneously. It helps reduce inflammation by lowering pro-inflammatory chemicals in the joint while increasing protective substances that support cartilage health. The electrical stimulation also activates the body's natural pain-relief systems, involving endorphins and other pain-reducing chemicals in both the brain and the affected joint area. Additionally, EA may improve blood flow to the knee and influence important cellular signaling pathways that control inflammation and cartilage breakdown.

The review found encouraging evidence that electroacupuncture can reduce knee pain and improve joint mobility in people with osteoarthritis. However, the authors note an important limitation: most existing studies have been small with short follow-up periods, making it difficult to know how well EA works long-term or to establish standardized treatment protocols. They emphasize the need for larger, well-designed clinical trials to confirm these benefits and determine optimal treatment approaches.

For patients considering electroacupuncture for knee osteoarthritis, this review suggests it may be a helpful addition to comprehensive care, though more research is needed to fully understand its long-term effectiveness. Always seek treatment from a licensed acupuncturist with experience in treating musculoskeletal conditions.

This narrative review examines electroacupuncture's mechanisms and clinical efficacy for knee osteoarthritis management. EA demonstrates multi-target therapeutic action through modulation of inflammatory cascades (suppressing pro-inflammatory mediators while promoting anti-inflammatory and chondroprotective factors), regulation of critical signaling pathways including NF-κB, MAPK, and Wnt/β-catenin, and engagement of central and peripheral neuromodulatory systems involving opioid, serotonergic, and cannabinoid receptors. Current evidence indicates EA reduces pain and improves joint mobility while potentially influencing cartilage metabolism and local hemodynamics. The review acknowledges significant methodological limitations in existing literature, including predominantly small sample sizes, short follow-up durations, and lack of standardized protocols. Clinical takeaway: While EA shows promise as a non-pharmacological adjunct in integrated KOA management with mechanistic plausibility across multiple biological systems, practitioners should recognize that definitive evidence requires large-scale, rigorously designed RCTs with extended follow-up to establish optimal dosing parameters and validate sustained clinical benefits.